Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemoperfusion or Plasma Exchange in ACLF
NCT04013113Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Transplant free survival at Day 28. Status: unknown.
Beyond the preview
Go deeper on NCT04013113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013113.